LINC02265: A Potential Drug Target and Biomarker (G101060498)

Target Name: LINC02265

NCBI ID: G101060498

LINC02265

Other Name(s): Long intergenic non-protein coding RNA 2265, transcript variant 1 | long intergenic non-protein coding RNA 2265 | Long intergenic non-protein coding RNA 2265, transcript variant 2

LINC02265: A Potential Drug Target and Biomarker

LINC02265 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of inflammation and cellular signaling. As a result, LINC02265 has been identified as a potential drug target and biomarker for a variety of diseases.

One of the key features of LINC02265 is its ability to interact with various signaling pathways. It has been shown to play a role in the regulation of T cell responses, and has been shown to interact with molecules that are involved in the T cell response, such as the chemokine CD40. Additionally, LINC02265 has also been shown to interact with molecules involved in inflammation and cellular signaling, such as the transcription factor NF-kappa-B and the protein ID4.

Another feature of LINC02265 is its ability to modulate the expression of various genes. Studies have shown that LINC02265 can bind to DNA and regulate the expression of genes involved in inflammation, cellular signaling, and metabolism. This suggests that LINC02265 may have a variety of different functions, including the regulation of inflammation and cellular signaling.

In addition to its potential drug target and biomarker properties, LINC02265 is also of interest due to its potential role in the development of certain diseases. Studies have shown that individuals with certain genetic variations in the LINC02265 gene are at increased risk for the development of certain diseases, including heart disease and diabetes. This suggests that LINC02265 may be an important factor in the development of these diseases, and that its manipulation may be a promising approach for the development of new treatments.

Overall, LINC02265 is a protein that has a variety of different functions, including its role as a potential drug target and biomarker. Its interaction with various signaling pathways and its ability to modulate the expression of various genes make it an attractive target for research into the development of new treatments for a variety of diseases. Further research is needed to fully understand its function and potential applications.

Protein Name: Long Intergenic Non-protein Coding RNA 2265

The "LINC02265 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02265 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets